(Q33906524)
Statements
1 reference
Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5) (English)
1 reference
Andres Forero-Torres
1 reference
Jatin Shah
1 reference
Tina Wood
1 reference
James Posey
1 reference
Ronda Carlisle
1 reference
Catherine Copigneaux
1 reference
Feng Roger Luo
1 reference
Slawomir Wojtowicz-Praga
1 reference
Ivor Percent
1 reference
Mansoor Saleh
1 reference
1 February 2010
1 reference
1 reference
25
1 reference
13-19
1 reference
Identifiers
1 reference
1 reference
1 reference